Seeing Is Believing
ATNM is currently covered by 1 analysts with an average price target of $3.7. This is a potential upside of $2.44 (193.65%) from yesterday's end of day stock price of $1.26.
Actinium Pharmaceuticals's activity chart (see below) currently has 0 price targets and 19 ratings on display. The stock rating distribution of ATNM is 100% BUY.
Highest price target for ATNM is $4, Lowest price target is $4, average price target is $3.7.
Most recent stock forecast was given by JOSEPH PANTGINIS from HCWAINWRIGHT on 15-Nov-2024. First documented stock forecast 04-Jun-2020.
Currently out of the existing stock ratings of ATNM, 16 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$2.8 (233.33%)
$4
1 months 18 days ago
(15-Nov-2024)
0/16 (0%)
$2.44 (156.41%)
What is ATNM (Actinium Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ATNM (Actinium Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ATNM (Actinium Pharmaceuticals)?
Which analyst is the currently most bullish on ATNM (Actinium Pharmaceuticals)?